SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037200
Filing Date
2016-08-11
Accepted
2016-08-11 17:27:18
Documents
49
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20160720_10q.htm 10-Q 1171063
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14805
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14929
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6296
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6421
  Complete submission text file 0001437749-16-037200.txt   3996744

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20160630.xml EX-101.INS 589455
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20160630.xsd EX-101.SCH 36603
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20160630_cal.xml EX-101.CAL 35025
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20160630_def.xml EX-101.DEF 304643
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20160630_lab.xml EX-101.LAB 235485
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20160630_pre.xml EX-101.PRE 312232
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 161825557
SIC: 2834 Pharmaceutical Preparations